Skip to main content
Top

Drugs

Issue 6/2024

Content (12 Articles)

Therapeutic Potential of Lipoprotein(a) Inhibitors

  • Open Access
  • Leading Article

Stephen J. Nicholls

Postpartum Depression: A Clinical Review of Impact and Current Treatment Solutions

Cindy-Lee Dennis, Daisy R. Singla, Hilary K. Brown, Katarina Savel, Crystal T. Clark, Sophie Grigoriadis, Simone N. Vigod

Anti-IL-5 Pathway Agents in Eosinophilic-Associated Disorders Across the Lifespan

Carlo Lombardi, Pasquale Comberiati, Erminia Ridolo, Marcello Cottini, Mona Rita Yacoub, Silvia Casagrande, Matteo Riccò, Marco Bottazzoli, Alvise Berti

Sex-Based Outcomes of Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention: A Pairwise and Network Meta-Analysis

Thomas A. Agbaedeng, Jean Jacques Noubiap, Kirsty A. Roberts, Derek P. Chew, Peter J. Psaltis, Azmeraw T. Amare

Crovalimab: First Approval

Sohita Dhillon

Tegileridine: First Approval

Sohita Dhillon

Ensitrelvir Fumaric Acid: First Approval

Yahiya Y. Syed

Cefepime/Enmetazobactam: First Approval

Susan J. Keam

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images